CAS: 66607-27-0; 3-Iodo-1H-Indazole

该化合物是一种卤化异氮衍生物,广泛用作有机合成和制药研究的多用途中间体,其主要优点包括:在苏素基-米亚乌拉和Buchwald-Hartwig等交叉反应中具有高度的回动性,能够高效地构建复杂的热环框架.3级的碘替代成分提高了其在金属催化转化中的效用,提供了精确的功能化机会.这一化合物在药用化学中对于开发基于非氮的生物活性分子(包括动脉抑制剂和抗微生物剂)特别宝贵.它在标准处理条件下的稳定,与各种反应条件的兼容性进一步突出了其在合成应用中的实用性.

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号271-44-3 吲唑 | CAS号679794-95-7 3-trimethylsily... | CAS号40598-94-5 3-溴吲唑 | CAS号2596-89-6 3H-Indazol-3-im... | CAS号7647-01-0 盐酸 | CAS号43120-28-1 1H-吲唑-3-羧酸甲酯 | CAS号214541-51-2 3-(3-吲唑)丙酸 | CAS号205643-28-3 1-苄基-3-碘-1H-吲唑 | CAS号6814-68-2 3-乙基胺吲唑 | CAS号52088-10-5 3-碘-1-甲基-1H-吲唑 | CAS号49572-64-7 3-碘-2-甲基-2H-吲唑 | CAS号170632-47-0 利非西呱 | CAS号290368-00-2 N-(叔丁氧羰基)-3-碘吲唑 | CAS号65452-73-5 3-(4-methylphen... | CAS号918440-06-9 2-[(3-iodoindaz...

合成工艺路线路线简述

    2-Methylbenzene Diazonium置于碘,Potassium Acetate,Potassium Hydroxide体系中,用 氯仿,N,N-二甲基甲酰胺 作为反应溶剂,化学反应 8.0H,反应生成 3-碘吲唑
    参考文献:Identification Of Novel Inhibitors Of Aurora A With A 3-(Pyrrolopyridin-2-yl)Indazole Scaffold
    标题:Identification Of Novel Inhibitors Of Aurora A With A 3-(Pyrrolopyridin-2-yl)Indazole Scaffold
    摘要:A Novel Series Of 3-(Pyrrolopyridin-2-yl)Indazole Derivatives Were Synthesized And Biologically Evaluated For Their Anti-Proliferative Effects On Five Human Cancer Cell Lines. As A Result,All Of Them Exhibited Vigorous Potency Against Hl60 Cell Line With Ic50 Values Ranging From Singe Digital Nanomolar To Micromolar Level. Besides,A Majority Of Them Displayed Modest To Good Antiproliferative Activities Against The Other Four Cell Lines,Including Kb,Smmc-7721,Hct116,And A549. Particularly,Compound 2Y,As The Most Distinguished One In This Series,Demonstrated Ic50 Values Of 8.3 Nm And 1.3 Nm Against Hl60 And Hct116 Cell Lines,Respectively. Afterwards,For Exploring The Molecular Target,Compounds 2D,2G And 2Y Were Further Selected To Evaluate The Inhibitory Activities Against A Panel Of Kinases. Finally,They Were Identified To Be Targeting Aurora A Kinase With Significant Selectivity Over Other Kinases,Such As Chk1,Cdk2,Mek1,Gsk3 Beta,Braf,Ikk Beta And Pkc. (C) 2015 Elsevier Ltd. All Rights Reserved.
    DOI:10.1016/j.Bmc.2015.02.004

    海关参考信息

    专利信息


    专利号:US-2006116519-A1
    优先权日:2004-11-17
    标 题:Synthesis of 5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester
    发明人:MA CHUNRONG; TIAN QINGPING
    权利人:AGOURON PHARMA
    摘要:The present invention relates to novel synthetic methods for the preparation of intermediates of 3{5-[3-(4,6-Difluoro-1H-benzoimidazol-2-yl)-1H-indazol-5-yl]4-methyl-pyridin-3-yl methyl}-ethyl-amine.

    专利号:WO-2015131100-A1
    优先权日:2014-02-28
    标题:Ligand-controlled c(sp3)-h arylation and olefination in synthesis of unnatural chiral alpha amino acids
    发明人:YU JIN-QUAN
    权利人:SCRIPPS RESEARCH INST
    摘要:The use of ligands to tune the reactivity and selectivity of transition metal-catalysts for C(-sp3)-H bond functionalization is a central challenge in synthetic organic chemistry. Herein, we report a rare example of catalyst-controlled C(sp3)-H arylation using pyridine and quinoline derivatives: the former promotes exclusive monoarylation, whereas the latter activates the catalyst further to achieve diarylation. Successive application of these ligands enables the sequential diarylation of a methyl group in an alanine derivative with two different aryl iodides, affording a wide range of β-Ar-p-Ar ' -cc-amino acids with excellent levels of diastereoselectivity (d.r. > 20:1). Both configurations of the β-chiral center can be accessed by choosing the order in which the aryl groups are installed. The use of a quinoline derivative as a ligand also enables C(sp3)-H olefination of a protected alanine.

    专利号:WO-2008022467-A1
    优先权日:2006-08-25
    标 题 :2-substituted azain doles and 2 substituted thienopyrroles, their precursors and novel processes for the preparation thereof
    发明人:LAUTENS MARK; YUEN JOSEPHINE; FANG YUANQING
    权利人:LAUTENS MARK; YUEN JOSEPHINE; FANG YUANQING
    摘要:The present invention relates generally to processes for the chemical synthesis of azaindole and thienopyrrole compounds, in particular azaindole and thienopyrrole compounds that are substituted at the 2-position of the azaindole or thienopyrrole ring, and optionally at additional locations of the azaindole or thienopyrrole ring such as the 1- and/or 3-position, compounds prepared by such processes, and synthetic precursors of such processes. More particularly, the present invention relates to the preparation of 2- substituted azaindoles from an ortho-gem-dihalovinylaminopyridine or from an ortho- gem-dihalovinylaminopyridine N-oxide compound and an organoboron reagent using a palladium metal pre-catalyst, base and a ligand. The present invention also relates to the preparation of 2-substituted thienopyrroles from an ortho-gem-dihalovinylthiophene compound and an organoboron reagent using a palladium metal pre-catalyst, base and a ligand. The present invention also relates to processes for the production of ortho-gem- dihalovinylaminopyridines which are useful as starting materials in the production of 2- substituted azaindoles, and novel compounds prepared by the processes. The present invention also relates to processes for the production of ortho-gem-dihalovinylthiophenes which are useful as starting materials in the production of 2-substituted thienopyrroles, and novel compounds prepared by the processes. Formulae (V) and (VII).

    专利号:WO-2024193328-A1
    优先权日:2023-03-20
    标题 :Indazole substituted podophyllotoxin derivative, preparation method therefor, and use thereof
    发明人:TANG YAJIE; ZHAO WEI; TANG YUNZHI
    权利人:TANG YAJIE
    摘要:An indazole nitrogen-substituted podophyllotoxin derivative represented by formula (V), a synthesis method therefor, and a use thereof. Different substituents, such as methyl, ethyl, propyl, benzyl, a fluorine atom, a chlorine atom, a bromine atom, an iodine atom, etc., are respectively introduced into the 1 and 3 positions of indazole podophyllotoxin to obtain a compound represented by formula (V) having significantly improved antitumor activity.
    南京新斯特生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.nstbio.com
    企业联系电话:025-85331029,18915981017👤
    📞南京新斯特生物科技有限公司 ⚠️参考联系方式
    联系人:杨女士
    电话:025-85331029,18915981017
    手机:18915981017
    传真:025-85331829
    邮箱:sales@nstbio.com
    通信地址: 江苏省南京市栖霞区纬地路9号江苏省生命科技创新园F6栋10楼
    邮编: 210010
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省南京市栖霞区纬地路9号江苏省生命科技创新园F6栋10楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    烟台知数医药化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.zhishumedicine.com
    企业联系电话:0535-5482128👤
    📞烟台知数医药化工有限公司 ⚠️参考联系方式
    联系人:郝志风
    电话:0535-5482128
    手机:18660030801
    传真:0535-5989245;5482130
    邮箱:sales@widepharmtech.com
    通信地址: 烟台市桃村镇海口路103号
    邮编: 264000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:烟台市桃村镇海口路103号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    常州瑞明药业股份有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.ruimingpharm.com
    企业联系电话:0519-86920910;18261172629;18118380910👤
    📞常州瑞明药业股份有限公司 ⚠️参考联系方式
    联系人:夏文华
    电话:0519-86920910;18261172629;18118380910
    手机:18261172629;18118380910
    传真:0519-86920912
    邮箱:swm@ruimingpharm.com
    通信地址: 江苏省常州市龙江北路1558号
    邮编: 213127
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省常州市龙江北路1558号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Sapeta, K.; Kerr, M. A., Science of Synthesis Knowledge Updates, (2011) 1, 60.
    摘要:Götzinger, A. C.; Müller, T. J. J., Science of Synthesis Knowledge Updates, (2017) 3, 201.
    摘要:Sapeta, K.; Kerr, M. A., Science of Synthesis Knowledge Updates, (2011) 1, 56.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知